These mutations have been identified in frontotemporal dementia and parkinsonism-linked to chromosome 17 (FTDP-17) related taupathology and are widely used to recapitulate AD-like tau pathology in in vivo models [14]. This evidence concerns the gene MAPT and Alzheimer disease.